Clinical Trial Update: Comparison of Adding EMEND to PONV/PDNV Treatment Regimen [NA]

View source ↗

Summary

The trial evaluating adding EMEND (aprepitant) to a postoperative nausea and vomiting regimen has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• EMEND (aprepitant)

Snippet

Sponsor: University of Nebraska | Conditions: Postoperative Nausea and Vomiting | NA | Status: WITHDRAWN